Oncotarget has in the past years offered medical practitioners and researchers with valuable scientific information concerning the various diseases that affect humans. The biomedical journal has encouraged their readers to look forward to their recent publication of scientific issues in the different platforms including PubMed, Web of Science, PubMed Central, Scopus, among many others. The particular texts that the texts that the firm has been publishing will see a significant number of individuals gain information concerning their health issues, and probably get them addressed before its too late, particularly chronic diseases like cancer.
The firm also works in collaboration with other scientific companies, archives as well as indexes to come up with a well-composed journal and make it available to all their readers worldwide. Oncotarget is usually availed to its readers twice weekly, and in some instances, it also covers a broad range of topics beyond oncology, including the immunity of people, aging and many other issues that may be of importance to their readers. The free access nature of the journal has seen it receive a high number of readers and more people have showered praises on it for the valuable information they offer o their readers. Besides, the weekly journal has received a lot of accreditation from a significant number of people and received amendments from the Committee on Publication Ethics due to their exceptional contributions to the healthy life of people.
Besides, Oncotarget also publishes on other fields beyond oncology and addresses various issues chronology, autophagy, and many others. The firm has always strived to offer their customers with high-quality publications to ensure that they highly benefit from them. Besides, the journal has provided research gurus with exclusive information which they can use to come up with appropriate cures for many chronic diseases. According to MEDLINE, Oncotarget has continued to equip readers with knowledge on concerning their health issues and through their publication of fundamental science research papers. The firm has been viewed as one of the most prominent publishers of journals rich in information and will now be availing their publications to their readers twice weekly, on Tuesday and Friday, exclusively.